Trial intelligence / Profile preview

Intranasal dexmedetomidine for sedation during vacuum aspiration abortion

ChiCTR-IPR-15007141Phase 4Not yet recruiting

Sponsor
The Second Affiliated Hospital of Dalian Medical University
Start
Oct 2015
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in anxiety disorder comparing Propofol, Propofol + sulfentanil and Propofol + dexmedetomidine (3 arms). Primary endpoint: Dosage of propofol. Planned start Oct 2015; status: not yet recruiting.

02

Drugs

dexmedetomidinepropofolsufentanil
03

Conditions

anxiety disorder

Beyond the preview

Go deeper on ChiCTR-IPR-15007141.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-15007141.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call